[EN] METHODS OF USING EHMT2 INHIBITORS IN TREATING OR PREVENTING BLOOD DISORDERS<br/>[FR] PROCÉDÉS D'UTILISATION D'INHIBITEURS DE L'EHMT2 DANS LE TRAITEMENT OU LA PRÉVENTION DE TROUBLES DU SANG
申请人:EPIZYME INC
公开号:WO2019079607A1
公开(公告)日:2019-04-25
The present disclosure relates to a method of preventing or treating a blood disorder (e.g., sickle-cell disease) via administering an EHMT2 inhibitor compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.